M/16/063 - Fannin Limited (DCC plc) / Medisource Ireland Limited [2017] IECompA m16063 (17 January 2017)

M/16/063 - Fannin Limited (DCC plc) / Medisource Ireland Limited [2017] IECompA m16063 (17 January 2017)

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in any market for goods or services in the State and therefore cleared the transaction under Phase 1 review.

Parties
Acquirer: Fannin Limited; Parent Company of Acquirer: DCC plc; Target: Medisource Ireland Limited
Jurisdiction
Ireland
Judgment Date
17 January 2017
Procedural Posture
Merger Control / Phase 1 Clearance
Outcome
cleared
Legal Topics
Merger Control, Pharmaceutical Sector
Competition Law Merger Control Pharmaceutical Sector

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2 Amounts and remedies 2
Sign in to unlock

Parties

Fannin Limited

Acquirer

DCC plc

Parent Company of Acquirer

Medisource Ireland Limited

Target

Procedural Posture

Merger Control / Phase 1 Clearance

Legal Issues

  1. 1 Whether the proposed acquisition would substantially lessen competition in any market for goods or services in the State.

Ratio Decidendi

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in any market for goods or services in the State and therefore cleared the transaction under Phase 1 review.

Court Disposition

cleared

Orders

  • The proposed acquisition by Fannin Limited of the entire issued share capital and sole control of Medisource Ireland Limited is cleared.